Institute of Medicine (U.S.). Board on Population Health and Public Health Practice, Institute of Medicine (U.S.). Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process, ebrary, Inc, & Wizemann, T. M. (2011). Public health effectiveness of the FDA 510(k) clearance process: Balancing patient safety and innovation : workshop report. National Academies Press.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
Institute of Medicine (U.S.). Board on Population Health and Public Health Practice, Institute of Medicine (U.S.). Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process, Inc ebrary, and Theresa M. Wizemann. Public Health Effectiveness of the FDA 510(k) Clearance Process: Balancing Patient Safety and Innovation : Workshop Report. Washington, D.C.: National Academies Press, 2011.
Successfully copied to clipboard
Copying to clipboard failed
ציטוט MLA
Institute of Medicine (U.S.). Board on Population Health and Public Health Practice, et al. Public Health Effectiveness of the FDA 510(k) Clearance Process: Balancing Patient Safety and Innovation : Workshop Report. National Academies Press, 2011.
Successfully copied to clipboard
Copying to clipboard failed
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.